BAJAJ BROKING

Notification close image
No new Notification messages
card image
GNG Electronics IPO is Open!
Apply for the GNG Electronics IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Patel Chem Specialities IPO: Things Smart Investors Need to Know

Patel Chem Specialities Limited (PCSL), incorporated in 2008, is involved in the production and export of pharmaceutical excipients and specialty chemicals. The company’s product line includes widely used compounds such as binders, disintegrants, thickeners, stabilisers, and gelling agents that support multiple industries including pharmaceuticals, food, cosmetics, and industrial applications. With manufacturing facilities located in Vatva, Ahmedabad, and Talod, Himmatnagar, the company adheres to recognised quality certifications like US-DMF and GMP, enabling large-scale production.

The facility spans 7,000 square yards and holds an annual production capacity of more than 7,200 MT. The setup is supported by departments such as production, R&D, quality control, packaging, and warehousing. PCSL has built a presence in global markets such as East Asia, Europe, the Middle East, North America, and Southeast Asia. Its product portfolio includes Rheollose®, Disolwell®, Swellcal®, and AmyloTab™, catering to a wide range of functional needs.

For more details, visit the Patel Chem Specialities IPO page.

Patel Chem Specialities IPO Details and Objectives

Details

Information

IPO Date

July 25, 2025 to July 29, 2025

Issue Size

70,00,000 shares

(aggregating up to ₹58.80 Cr)

Price Band

₹82 to ₹84 per share

Lot Size

1600 shares

Listing At

BSE SME

Market maker

Globalworth Securities Limited

Purpose of the IPO

  • Funding capital expenditure to set up plant at Indrad, Mahesana for manufacturing Croscarmellose Sodium (“CCS”), Sodium Starch Glycolate (“SSG”) – Corn Starch Base & Potato Starch Base and Calcium Carboxymethylcellulose (CMC)

  • General Corporate Purposes

Timeline of Patel Chem Specialities IPO

Event

Date

IPO Open Date

Fri, Jul 25, 2025

IPO Close Date

Tue, Jul 29, 2025

Tentative Allotment

Wed, Jul 30, 2025

Initiation of Refunds

Thu, Jul 31, 2025

Credit of Shares to Demat

Thu, Jul 31, 2025

Tentative Listing Date

Fri, Aug 1, 2025

Cut-off time for UPI mandate confirmation

5 PM on July 29, 2025

Pricing & Lot Size of Patel Chem Specialities IPO

Price Band for the IPO

  • ₹82 to ₹84 per share

Minimum Lot Size and Application Details

Application

Lots

Shares

Amount

Individual investors (Retail) (Min)

2

3,200

₹2,68,800

Individual investors (Retail) (Max)

2

3,200

₹2,68,800

S-HNI (Min)

3

4,800

₹4,03,200

S-HNI (Max)

7

11,200

₹9,40,800

B-HNI (Min)

8

12,800

₹10,75,200

How to Apply for the Patel Chem Specialities IPO?

Online Application Process

  • Log in to Your Trading Account Access your trading account through your broker’s platform.

  • Navigate to the IPO Section Go to the IPO section to view active IPO listings.

  • Select Patel Chem Specialities IPO Find "Patel Chem Specialities IPO" and click on the ‘Apply’ button.

  • Enter Application Details Specify the number of lots (minimum lot size: 1600 shares) and the bid price within the range of ₹82 to ₹84 per share.

  • Provide Your UPI ID Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.

  • Review and Submit Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on July 29, 2025, to complete your application process.

Financial Health and Performance

Key Financial Metrics

  • Total Assets: Grew from ₹37.08 crore in FY23 to ₹65.31 crore as of March 2025.

  • Revenue: Reached ₹105.55 crore in FY25.

  • Profit After Tax (PAT): Stood at ₹10.57 crore for March 2025.

  • Net Worth: Recorded at ₹35.40 crore in FY25.

  • Reserves and Surplus: Recorded at ₹17.53 crore (March 2025), growing steadily over the years.

  • EBITDA: Stood at ₹15.80 crore in March 2025.

Recent Performance and Growth Prospects

  • The company has reported a steady increase in its total assets over the past financial years, indicating an expansion in operational scale.

  • Revenue generation has shown consistent progress, reflecting growing demand for its products in both domestic and international markets.

  • Profitability has remained stable, suggesting effective cost management and operational efficiency.

  • The net worth of the company has seen a healthy rise, supporting its financial position and business sustainability.

  • Reserves and surplus have grown over time, contributing to the company's internal strength and capacity for reinvestment.

  • Operational earnings have maintained a positive trend, reinforcing the company's ability to generate income from its core business activities.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • The company operates in a highly specialised chemical segment, which may be sensitive to regulatory changes, supply chain disruptions, or fluctuations in raw material availability.

  • Expansion into new production facilities, such as the upcoming Indrad plant, may involve execution-related challenges and uncertainties associated with capacity scaling and market demand.

Opportunities and Growth Potential

  • The IPO proceeds are aimed at funding capital expenditure for new product lines, indicating a potential increase in production capacity and market reach.

  • With an established presence across global markets and a growing product portfolio, the company is positioned to tap into rising demand for pharmaceutical excipients and specialty chemicals across multiple sectors.

Key Performance Indicator (KPI)

KPI

Values

ROE

29.85%

ROCE

36.26%

Debt/Equity

0.42

RoNW

24.32%

PAT Margin

10.01%

EBITDA Margin

14.97%

Price to Book Value

4.11

Patel Chem Specialities IPO Registrar & Lead Managers

Registrar

Lead Manager(s)

MUFG Intime India Private Limited (Link Intime)

Cumulative Capital Private Limited

Company Address of Patel Chem Specialities Ltd

Patel Chem Specialities Ltd.

Plot No. 272/4-5,

Phase II, G.I.D.C Industrial Estate,

Vatva Road

Ahmedabad, Gujarat, 382445

Phone: 91- 9712999854

Email: cs@patelchem.com

Website: http://www.patelchem.com/

Conclusion

Patel Chem Specialities Limited operates in the field of pharmaceutical excipients and specialty chemicals, with a focus on manufacturing compounds that serve various industries. The company’s production units in Gujarat and its presence in global markets contribute to its operational spread. The product portfolio includes functional ingredients used in pharmaceuticals, food, cosmetics, and industrial applications.

The upcoming IPO is aimed at supporting capital expenditure for a new manufacturing facility and meeting general corporate needs. With defined financial performance and a targeted expansion plan, the offering outlines both operational developments and sector-focused initiatives.

Interested in more opportunities? Check out our Upcoming IPO section for new listings, and don’t forget to check your IPO allotment status for Patel Chem Specialities IPO. 

Share this article: 

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.2 App Rating

icon-with-text

4 Languages

icon-with-text

₹5600+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|